+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H



Effects of U-50,488H on isolated atria from rats chronically treated with the kappa-opioid agonist, U-50,488H



Journal of Autonomic Pharmacology 18(6): 371-375



The present investigation was aimed at determining if chronic activation of kappa- or mu-opioid receptors induce development of tolerance and dependence to kappa-opioid agonists on the isolated left atria of the rat. Tolerance to a kappa-agonist (specific tolerance) was induced by chronic administration of U-50,488H, a selective kappa-agonist (15 mg kg(-1) i.p. twice a day for 4 days). The animals were rendered tolerant to morphine by subcutaneous implantation of morphine pellets (75 mg per pellet) for 7 days. Tolerance to U-50,488H was observed after its chronic administration and was revealed as a rightward shift of the concentration-response curve, it was accompanied by a decrease in the maximum response and in the slope. Preparations from morphine-treated rats were not tolerant to the selective kappa-agonist, that is, there was no cross-tolerance between mu- and kappa-agonists. Dependence to the kappa-agonist was tested by administration in the organ bath of Mr-2266 (preferential kappa-antagonist) or nor-binaltorphimine (nor-BNI; selective kappa-antagonist). The administration in the organ bath of the kappa-antagonists Mr-2266 or nor-BNI to preparations from U-50,488H-treated rats induced an increase in atrial force of contraction. In contrast, the administration of the kappa-antagonists to preparations from control rats induced a decrease in atrial force of contraction. These findings demonstrate that left atria from chronically U-50488H-treated rats exhibit tolerance to the negative inotropic effects of U-50,488H as well as opioid withdrawal after nor-BNI.

(PDF emailed within 1 workday: $29.90)

Accession: 045901355

Download citation: RISBibTeXText

PMID: 9915602



Related references

Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist. Brain Research 749(2): 347-350, 1997

The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats. Journal of Pharmacology and Experimental Therapeutics 264(2): 631-637, 1993

Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats. European Journal of Pharmacology 170(1-2): 47-51, 1989

Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis. Rheumatology 45(3): 295-302, 2005

Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis. Rheumatology (Oxford) 45(3): 295-302, 2006

Mu Opioid induced respiratory depression antagonized by kappa opioid agonist MR-2034 but not by U-50, 488H in freely moving rats. Regulatory Peptides 54(1): 215-216, 1994

Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist. Brain Research 337(2): 352-356, 1985

Anxiolytic effects and a putative site of action for the kappa opioid agonist U-50,488H. Society for Neuroscience Abstracts 19(1-3): 1786, 1993

A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. European Journal of Pharmacology 156(1): 173-176, 1988

The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats. Psychopharmacology 91(2): 189-192, 1987

Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. European Journal of Pharmacology 494(2-3): 139-146, 2004

Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H. Neuroscience Letters 176(1): 37-40, 1994

Studies on drug dependence Effects of a selective kappa-opioid agonist, U-50, 488H, an delta-opioid agonists-induced place preference. Japanese Journal of Pharmacology 64(SUPPL 1): 221P, 1994

Effects of the kappa-opioid receptor agonist U50,488H on volitional ethanol intake in the Lewis rat. Society for Neuroscience Abstracts 25(1-2): 1081, 1999